Criticizing Vaccine Prices Could Deter Pharmaceutical Companies From Developing Drugs For Poor Countries, Gates Says

The Guardian: Bill Gates dismisses criticism of high prices for vaccines
“Bill Gates has dismissed criticism by health campaigners of the high prices of some vaccines, warning that it only serves to deter pharmaceutical companies from working on life-saving products for poor countries. In an interview with The Guardian from a major international vaccine-funding conference in Berlin, … Gates denied that the cost of the new vaccine against pneumococcal disease was too high…” (Boseley, 1/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.